The CD95 system and the death of a lymphocyte

Seminars in Immunology

Volumn 9, Issue 1, 1997, Pages 59-68

  Matiba, Bernd ^a   Mariani, Sara M ^a   Krammer, Peter H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; CD95 (APO 1 Fas); CD95 (APO 1 Fas) ligand; gld; lpr

Indexed keywords

FAS ANTIGEN; LYMPHOCYTE ANTIGEN; SIGNAL PEPTIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL DEATH; CELL MEDIATED CYTOTOXICITY; GENE MUTATION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; T LYMPHOCYTE;

EID: 0031080108     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1996.0054     Document Type: Article

References (107)

1. 1. Smith CA, Davis T, Anderson D, Solam L, Beckman MP, Jerzy R, Dower SK, Cosman D, Goodwin RG (1990) A receptor for TNF defines an unusual family of cellular and viral proteins. Science 248:1019-1023
2. 3. Yonehara S, Ishi A, Yonehara M (1989) A cell killing mAb (anti-fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747-1753
3. 4. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushina S-I, Sameshima M, Hase A, Seto Y, Nagata S (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243
4. 5. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, Ponstingl H, Krammer PH (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 267:10709-10715
5. 6. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD (1994) Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263:1759-1762
6. 7. Knipping E, Debatin K-M, Stricker K, Heilig B, Eder A, Krammer PH (1995) Identification of soluble APO-1 in supernatants of human B and T cell lines and increased serum levels in B and T cell leukemias. Blood 85:1562-1569
7. 8. Cascino I, Fiucci G, Papoff G, Ruberti G (1995) Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J Immunol 154:2706-2713
8. 9. Leithäuser F, Dhein J, Mechtersheimer G, Koretz K, Brüderlein S, Henne C, Schmidt A, Debatin KM, Krammer PH, Möller P (1993) Constitutive and induced expression of APO-1, a new member of NGF/TNF receptor superfamily, in normal and neoplastic cells. Lab Invest 69:415-429
9. 10. Alderson JR, Armitage RJ, Maraskowsky E, Tough TW, Rouse E, Schooley K, Ramsdell F, Lynch DH (1993) Fas transduces activation signals in normal human T lymphocytes. J Exp Med 178:2231-2235
10. 11. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S (1993) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317
11. 12. Cohen PL, Eisenberg RA (1991) Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9:243-269
12. 13. Izui S, Kelley VE, Masuda K, Yoshida H, Roths JB, Murphy ED (1984) Induction of various autoantibodies by mutant gene lpr in several strains of mice. J Immunol 133:227-233
13. 14. Watson ML, Rao JK, Gilkeson GS, Ruiz P, Eicher EM, Pisetsky DS, Matsuzawa A, Rochelle JM, Seldin MF (1992) Genetic analysis of MRL lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease modifying loci. J Exp Med 176:1645-1656
14. 15. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middelton LA, Lin AY, Strober W, Lenardo MJ, Puck JM (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946
15. 16. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, De Viullarty JP (1995) APO-1/Fas (CD95) mutations in human lymphoproliferative syndrome associated with autoimmunity and defective apoptosis. Science 268:1347-1349
16. 17. Allen RD, Marshall JD, Roths JB, Sidman CL (1990) Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. J Exp Med 172:1367-1375
17. 18. Lynch DH, Watson ML, Alderson MR, Baum PR, Miller RE, Tough T, Gibson M, Davis-Smith T, Smith CA, Hunter K, Bhat D, Din W, Goodwin RG, Seldin MF (1994) The mouse fas ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1:131-136
18. 19. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S (1994) Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 76:969-976
19. 20. Suda T, Takahashi T, Golstein P, Nagata S (1993) Molecular cloning and expression of the Fas ligand, a novel member of the TNF family. Cell 75:1169-1178
20. 21. Adachi M, Watanabe-Fukunaga R, Nagata S (1993) Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen of lpr mice. Proc Natl Acad Sci USA 90:1756-1760
21. 22. Chu JL, Drappa J, Parnassa A, Elkon KB (1993) The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon ETn. J Exp Med 178:723-730
22. 23. Wu J, Zhou T, He J, Mountz JD (1993) Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med 178:461-468
23. 24. Watanabe D, Suda T, Hashimoto H, Nagata S (1995) Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J 14:12-18
24. 25. Mariani SM, Matiba B, Armandola EA, Krammer PH (1994) The APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. Eur J Immunol 24:3119-3123
25. 26. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364:806-809
26. + thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain MRL lpr/lpr. Proc Natl Acad Sci USA 90:10340-10344
27. 28. Russell JH, Rush B, Weaver C, Wang R (1993) Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA 90:4409-4413
28. 29. Gillette-Ferguson I, Sidman CL (1994) A specific intercellular pathway of apoptotic cell death is defective in the mature peripheral T cells of autoimmune lpr and gld mice. Eur J Immunol 24:1181-1185
29. 30. Alderson JR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell E, Lynch D (1995) Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181:71-77
30. 31. Dhein J, Walczak H, Bäumler C, Debatin KM, Krammer PH (1995) Autocrine T-cell suicide mediated by APO-1/(Fas/ CD95). Nature 373:438-441
31. 32. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR (1995) Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441-444
32. 33. Ju ST, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein M (1995) Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444-448
33. 34. Adachi M, Suematsu S, Kondo T, Ogasawara J, Tanaka T, Yoshida N, Nagata S (1995) Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nature Genet 11:294-300
34. 35. Andjelic S, Drappa J, Lacy E, Elkon KB, Nikolic-Zugic J (1994) The onset of Fas expression parallels the acquisition of CD8 and CD4 in fetal and adult thymocytes. Int Immunol 6:73-79
35. 36. Debatin KM, Süss D, Krammer PH (1994) Differential expression of APO-1 on human thymocytes: implications for negative selection? Eur J Immunol 24:753-758
36. + thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand. Eur J Immunol 25:2996-2999
37. + thymocytes by the anti-Fas antibody. J Exp Med 181:485-491
38. 39. Yonehara S, Nishimura Y, Kishil S, Yonehara M, Takazawa K, Tamatani T, Ishi A (1994) Involvement of apoptosis antigen Fas in clonal deletion of human thymocytes. Int Immunol 6:1849-1854
39. 40. Herron LR, Eisenberg RA, Roper E, Kakkanaiah NN, Cohen PL, Kotzin BL (1993) Selection of the T cell receptor repertoire in lpr mice. J Immunol 151:3450-3459
40. 41. Sidman CL, Marshall JD, van Boehmer H (1992) Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice. Eur J Immunol 22:499-504
41. + thymocytes in vitro does not require dedicated antigen-presenting cells. Eur J Immunol 23:669-674
42. 43. Adachi M, Suematsu S, Suda T, Watanabe D, Fukuyama H, Ogasawara J, Tanaka T, Yoshida N, Nagata S (1996) Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc Natl Acad Sci USA 93:2131-2136
43. 44. Amakawa R, Hakem A, Kundig TM, Matsuyama T, Simard JJL, Timms E, Wakeham A, Mittruecker H-W, Griesser H, Takimoto H, Schmits R, Shahinian A, Ohashi PS, Penninger JM, Mak TW (1996) Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 84:551-562
44. 45. Scott DE, Kisch WJ, Steinberg AD (1993) Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice. J Immunol 150:664-672
45. 46. Owen-Schaub LB, Yonehara S, Crump WL, Grimm EA (1992) DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 140:107-205
46. 47. Has C, Debatin KM, Jonker R, Krammer PH (1993) Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 5:625-630
47. 48. Mariani SM, Matiba B, Bäumler C, Krammer PH (1995) Regulation of cell surface APO-1/Fas (CD95) ligand by metalloproteases. Eur J Immunol 25:2303-2307
48. 49. Tanaka M, Suda T, Takahashi T, Nagata S (1995) Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 14:1129-1135
49. 50. Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S, Inoue S, Yoshino K, Okumura K, Yagita H (1995) Metalloproteinase-mediated release of human Fas ligand. J Exp Med 182:1777-1783
50. 51. Daniel PT, Krammer PH (1994) Activation induces sensitivity towards APO-1 (CD95) mediated apoptosis in human B cells. J Immunol 152:5624-5632
51. 52. Rothstein TL, Wang JKM, Panka DJ, Foote LC, Wang Z, Marshak-Rothstein A (1995) Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374:163-165
52. 53. Lasgresle C, Bella C, Daniel PT, Krammer PH, Defrance T (1995) Regulation of germinal center B cell differentiation. Role of the human APO-1/Fas (CD95) molecule. J Immnol 154:5746-5756
53. + T cells. Nature 376:181-183
54. 2+-independent T cell-mediated cytotoxicity. J Exp Med 177:195-200
55. 56. Walsh CM, Glass AA, Chiu V, Clark WR (1994) The role of Fas lytic pathway in a perforin-less CTL hybridoma. J Immunol 153:2506-2514
56. + T cell mediated cytotoxicity. J Immunol 152:1127-1133
57. + cytotoxic T cells. Proc Natl Acad Sci USA 91:4185-4189
58. 59. Hanabuchi S, Koyanagi M, Kawasaki A, Shinohara N, Matsuzawa A, Nishimura Y, Kobayashi Y, Yonehara S, Yagita H, Okumura K (1994) Fas and its ligand in a general mechanism of T cell mediated cytotoxicity. Proc Natl Acad Sci USA 91:4930-4934
59. 60. Kägi D, Ledermann B, Bürki K, Seiler P, Odermatt B, Olsen KJ, Podack ER, Zinkernagel RM, Hengartner H (1994) Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31-37
60. 61. Kägi D, Vignaux F, Ledermann B, Bürki K, Depraetere V, Nagata S, Hengartner H, Golstein P (1994) Fas and perforin pathways as major mechanisms of T-cell-mediated cytotoxicity. Science 265:528-530
61. 62. Lowin B, Hahne M, Mattmann C, Tschopp J (1994) Cytolytic T cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650-653
62. 63. Kojima H, Shinohara N, Hamaoka S, Someya-Shirota Y, Takagaki Y, Ohno H, Saito T, Katayama T, Yagita H, Okumura K, Shinkai Y, Alt FW, Matsuzawa A, Yonehara S, Takayama H (1994) Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1:357-364
63. 64. Ramsdell F, Seaman MS, Miller RE, Picha KS, Kennedy MK, Lynch DH (1994) Differential ability of Th1 and Th2 cells to express Fas ligand and to undergo activation-induced cell death. Int Immunol 6:1545-1553
64. 65. Vignaux F, Golstein P (1994) Fas based lymphocyte mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway? Eur J Immunol 24:923-927
65. 66. Arase H, Arase N, Saito T (1995) Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med 181:1235-1238
66. 67. Schulz M, Schuurmann HJ, Joergensen J, Steiner C, Meerloo T, Kägi D, Hengartner H, Zinkernagel RM, Schreier MH, Bürki K, Ledermann B (1995) Acute rejection of vascular heart allografts by perforin deficient mice. Eur J Immunol 25:474-480
67. 68. Larsen CP, Alexander DZ, Hendrix R, Ritchie SC, Pearson TC (1995) Fas-mediated cytotoxicity. An immunoeffector or immunoregulatory pathway in T-cell-mediated immune response? Transplantation 60:221-224
68. 69. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S (1992) The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen. J Immunol 148:1274-1279
69. 70. Braun MY, Lowin B, French L, Acha-Orbea H, Tschopp J (1996) Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med 183:657-661
70. 71. Baker MB, Altman NH, Podack ER, Levy RB (1996) The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J Exp Med 183:2645-2656
71. 72. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC (1995) A role for CD95 ligand in preventing graft rejection. Nature 373:630-631
72. 73. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189-1192
73. 74. Yagita H, Seino K-I, Kayagaki N, Okumura K (1996) CD95 ligand in graft rejection. Nature 379:682
74. 75. Hiromatsu K, Aoki Y, Makino M, Matsumoto Y, Mizuochi T, Gotoh Y, Nomoto K, Ogasawara J, Nagata S, Yoshikai Y (1994) Increased Fas antigen expression in murine retrovirus-induced immunodeficiency syndrome MAIDS. Eur J Immunol 24:2446-2451
75. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 175:331-340
76. 77. Gougeon ML, Montagnier L (1993) Apoptosis in AIDS. Science 260:1269-1270
77. 78. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA, Herzenberg LA (1995) Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus infected individuals. J Exp Med 181:2029-2036
78. 79. Debatin KM, Fahrig-Faissner A, Enenkel-Stoodt S, Kreuz W, Benner A, Krammer PH (1994) High expression of APO-1 (CD95) on T-lymphocytes from HIV infected children. Blood 83:3101-3103
79. 80. Kobayashi N, Hamamoto Y, Yamamoto N, Ishii A, Yonehara M, Yonehara S (1990) Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc Natl Acad Sci USA 87:9620-9624
80. 81. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, Debatin KM, Krammer PH (1995) Sensitization of T cell to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497-500
81. 82. Wang Z, Orlikowsky T, Dudhane A, Mittler R, Blum M, Lacy E, Riethmüller G, Hoffmann MK (1994) Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp-specific antibodies from AIDS patients. Eur J Immunol 24:1553-1557
82. 83. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH, Runkel L (1995) Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 182:1223-1230
83. 84. Tartaglia LA, Ayres TM, Wong GHW, Goeddel DV (1993) A novel domain within the 55 kda TNF receptor signals cell death. Cell 74:845-853
84. 85. Itoh N, Nagata S (1993) A novel domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem 268:10932-10937
85. 86. Tewari M, Dixit VM (1995) Fas and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem 270:3255-3260
86. 87. Itoh N, Tsuijimoto Y, Nagata S (1993) Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 151:621-627
87. 88. Jäattela M, Benedict M, Tewari M, Shayman JA, Dixit VM (1995) Bcl-x and Bcl-2 inhibit TNF-and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 10:2297-2305
88. 89. Beidler DR, Tewari M, Friesen PD, Poirier G, Dixit VM (1995) The baculovirus p35 protein inhibits Fas-and TNF-induced apoptosis. J Biol Chem 270:16526-16528
89. 90. Los M, van de Craen M, Penning L, Schenk H, Westendorp M, Baeuerle P, Dröge W, Krammer PH, Fiers W, Schulze-Osthoff K (1995) Requirement of an ICE/Ced-3 protease for Fas/ APO-1-mediated apoptosis. Nature 375:81-83
90. 91. Enari M, Hug H, Nagata S (1995) Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375:78-81
91. 92. Gulbins E, Bissonette R, Mahboubi A, Martin S, Nishika W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F, Kolesnick R, Altman A, Green D (1995) Fas-induced apoptosis is mediated via ceramide-initiated RAS signaling pathway. Immunity 2:341-351
92. 93. Taupin J-L, Tian Q, Kedersha N, Robertson M, Anderson P (1995) The RNA binding protein TIAR is translocated from the nucleus to the cytoplasm during Fas-mediated apoptotic cell death. Proc Natl Acad Sci USA 92:1629-1633
93. 94. Tian Q, Taupin J-L, Elledge S, Robertson M, Anderson P (1995) Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis. J Exp Med 182:865-874
94. 95. Cifone MG, De Maria R, Roncaioli P, Rippo MR, Azuma M, Lanier LL, Santoni A, Testi R (1994) Apoptotic signaling through CD95 (Fas/ Apo-1) activates an acidic sphingomyelinase. J Exp Med 177:1547-1552
95. 96. Tepper C, Jayadev S, Liu B, Bielawska A, Wollf R, Yonehara S, Hannun YA, Seldin MF (1995) Role of ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc Natl Acad Sci USA 92:8443-8447
96. 97. Latinis KM, Koretzky GA (1996) Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human T cells. Blood 87:871-875
97. 98. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75:641-652
98. 99. Fraser A, Evan G (1996) A licence to kill. Cell 85:781-784
99. 100. Sato T, Irie S, Kitada S, Reed JC (1995) FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268:411-413
100. 101. Stanger BZ, Leder P, Lee T-H, Kim E, Seed B (1995) RIP: a novel protein containing a death domain that interacts with Fas/ APO-1 (CD95) in yeast and causes cell death. Cell 81:513-523
101. 102. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM (1995) FADD, a novel death domain-containing protein interacts with the death domain of Fas and initiates apoptosis. Cell 81:505-512
102. 103. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D (1995) A novel protein that interacts with the death domain of Fas/ APO-1 contains a sequence motif related to the death domain. J Biol Chem 270:7795-7798
103. 104. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14:5579-5588
104. 105. Muzio M, Chinnaiyan AM, Kischkel F, O'Rourke K, Shevchenkom A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/ APO-1) death-inducing signalling complex. Cell 85:817-827
105. 106. Boldin MP, Goncharov TM, Goltsev YV, Wallach D (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/ APO-1 and TNF receptor-induced cell death. Cell 85:803-815
106. 107. Chow SC, Weis M, Kass GEN, Holmström TH, Eriksson JE, Orrenius S (1995) Involvement of multiple proteases during Fas mediated apoptosis in T lymphocytes. FEBS Lett 364:134-138
107. 108. Schlegel J, Peters I, Orrenius S (1995) Isolation and partial characterization of a protease involved in Fas induced apoptosis. FEBS Lett 364:139-142